Capital Investment Advisory Services’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,108
| Closed | -$22.7K | – | 985 |
|
|
2024
Q2 | $22.7K | Sell |
1,108
-6
| -0.5% | -$123 | ﹤0.01% | 759 |
|
|
2024
Q1 | $50.3K | Hold |
1,114
| – | – | 0.01% | 654 |
|
|
2023
Q4 | $52.6K | Sell |
1,114
-10
| -0.9% | -$472 | ﹤0.01% | 638 |
|
|
2023
Q3 | $45.5K | Buy |
1,124
+41
| +4% | +$1.66K | ﹤0.01% | 617 |
|
|
2023
Q2 | $115K | Hold |
1,083
| – | – | 0.01% | 524 |
|
|
2023
Q1 | $323K | Buy |
+1,083
| New | +$323K | 0.04% | 347 |
|
|
2022
Q2 | – | Sell |
-880
| Closed | -$294K | – | 827 |
|
|
2022
Q1 | $294K | Hold |
880
| – | – | 0.03% | 390 |
|
|
2021
Q4 | $286K | Sell |
880
-131
| -13% | -$42.6K | 0.03% | 391 |
|
|
2021
Q3 | $491K | Sell |
1,011
-16
| -2% | -$7.77K | 0.06% | 271 |
|
|
2021
Q2 | $477K | Sell |
1,027
-11
| -1% | -$5.11K | 0.06% | 283 |
|
|
2021
Q1 | $716K | Buy |
1,038
+50
| +5% | +$34.5K | 0.1% | 195 |
|
|
2020
Q4 | $730K | Buy |
988
+138
| +16% | +$102K | 0.11% | 196 |
|
|
2020
Q3 | $590K | Buy |
850
+19
| +2% | +$13.2K | 0.11% | 177 |
|
|
2020
Q2 | $705K | Sell |
831
-63
| -7% | -$53.4K | 0.14% | 138 |
|
|
2020
Q1 | $320K | Buy |
+894
| New | +$320K | 0.08% | 219 |
|
|
2019
Q4 | – | Sell |
-313
| Closed | -$35K | – | 643 |
|
|
2019
Q3 | $35K | Hold |
313
| – | – | 0.01% | 643 |
|
|
2019
Q2 | $53K | Buy |
+313
| New | +$53K | 0.02% | 538 |
|